Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-23

Clinical Trial Update: Long-Term Follow-up Safety After DDS Implantation With/Without CDNF Infusions [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial assessing long-term safety of DDS implantation with or without CDNF infusions in Parkinson disease and related movement/neurodegenerati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CDNF (Cerebral Dopamine Neurotrophic Factor)

Snippet

Sponsor: Renishaw | Conditions: Parkinson Disease, Movement Disorders | Phase 1, Phase 2 | Status: UNKNOWN